Literature DB >> 8382038

5-Propyl-2-deoxyuridine induced interference with glycosylation in herpes simplex virus infected cells. Nature of PdU-induced modifications of N-linked glycans.

S Olofsson1, I Sjöblom, K Hellstrand, D Shugar, C Clairmont, C Hirschberg.   

Abstract

In herpes simplex virus-infected (HSV) cells, the antiviral nucleoside analogue 5-n-propyl-2'-deoxyuridine (PdU) may, under certain circumstances, induce a pattern of interference with late steps in formation of N-linked glycans, resulting in increased availability of viral glycoproteins for neutralizing antibodies. The PdU-induced changes in N-linked glycans, released by pronase digestion of the HSV-specified glycoprotein gC-1, were investigated by using lectin affinity chromatography and Bio-Gel P6 gel filtration of glycans, radiolabelled with [3H]galactose or [3H]glucosamine. PdU-treatment of HSV-infected cells totally inhibited addition of sialic acid and reduced the amount of galactose incorporated into N-linked glycans by 70%. In addition, the PDU-treatment caused a decrease in oligosaccharides with affinity for Phaseoulus vulgaris leuco-agglutinin and erythro-agglutinin, and an increase in Lens culinaris lectin (LCA)-binding oligosaccharides, suggesting a PdU-induced shift from multi-branched to moderately branched structures. This shift was also found in HSV-infected B16 mouse melanoma cells, where the large content of multi-branched oligosaccharides contributes to the metastatic potential. The LCA-binding glycans from PdU-treated cells were smaller and contained less galactose units than corresponding structures from untreated cells. In a cell-free system, PdU 5'-monophosphate inhibited the translocation of UDP-GlcNAc, and, to a smaller extent, also the translocation of UDP-galactose into Golgi vesicles, suggesting that nucleotide sugar translocation is one important target for the PdU-induced interference with glycosylation in HSV-infected cells.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8382038     DOI: 10.1007/bf01309437

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  27 in total

1.  GROWTH AND CYTOPATHIC EFFECT OF RUBELLA VIRUS IN A LINE OF GREEN MONKEY KIDNEY CELLS.

Authors:  A GUENALP
Journal:  Proc Soc Exp Biol Med       Date:  1965-01

2.  A nonmutagenic thymidine analog with antiviral activity. 5-Ethyldeoxyuridine.

Authors:  M Swierkowski; D Shugar
Journal:  J Med Chem       Date:  1969-05       Impact factor: 7.446

3.  Oligosaccharide specificities of Phaseolus vulgaris leukoagglutinating and erythroagglutinating phytohemagglutinins. Interactions with N-glycanase-released oligosaccharides.

Authors:  E D Green; J U Baenziger
Journal:  J Biol Chem       Date:  1987-09-05       Impact factor: 5.157

Review 4.  Synthesis and antiviral properties of 5-vinylpyrimidine nucleoside analogs.

Authors:  E De Clercq; R T Walker
Journal:  Pharmacol Ther       Date:  1984       Impact factor: 12.310

5.  5-substituted arabinofuranosyluracil nucleosides: synthesis and antiviral properties.

Authors:  T Kulikowski; Z Zawadzki; E De Clercq; D Shugar
Journal:  Acta Biochim Pol       Date:  1984       Impact factor: 2.149

6.  Beta 1-6 branching of Asn-linked oligosaccharides is directly associated with metastasis.

Authors:  J W Dennis; S Laferté; C Waghorne; M L Breitman; R S Kerbel
Journal:  Science       Date:  1987-05-01       Impact factor: 47.728

7.  Swainsonine: an inhibitor of glycoprotein processing.

Authors:  A D Elbein; R Solf; P R Dorling; K Vosbeck
Journal:  Proc Natl Acad Sci U S A       Date:  1981-12       Impact factor: 11.205

8.  Swainsonine causes the production of hybrid glycoproteins by human skin fibroblasts and rat liver Golgi preparations.

Authors:  D R Tulsiani; O Touster
Journal:  J Biol Chem       Date:  1983-06-25       Impact factor: 5.157

9.  Demonstration and mapping of highly carbohydrate-dependent epitopes in the herpes simplex virus type 1-specified glycoprotein C.

Authors:  I Sjöblom; M Lundström; E Sjögren-Jansson; J C Glorioso; S Jeansson; S Olofsson
Journal:  J Gen Virol       Date:  1987-02       Impact factor: 3.891

Review 10.  Inhibitors of protein glycosylation and glycoprotein processing in viral systems.

Authors:  R Datema; S Olofsson; P A Romero
Journal:  Pharmacol Ther       Date:  1987       Impact factor: 12.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.